Literature DB >> 7533575

Induced mutagenesis by bleomycin in the purple sulfur bacterium Thiocapsa roseopersicina.

V Pavón1, I Esteve, R Guerrero, A Villaverde, N Gaju.   

Abstract

Cell death and mutagenesis in bleomycin-treated cells of Thiocapsa roseopersicina (a purple sulfur bacterium) was studied by cultivation in a semisolid medium (agar-shake technique). This technique has also proven useful in assessing the frequency of antibiotic mutations by detecting and counting individual colonies of Thiocapsa roseopersicina. The frequencies of spontaneous mutants resistant to ampicillin, rifampicin, cloramphenicol, tetracycline, kanamycin, streptomycin, and neomycin were also studied: they ranged between 2 x 10(-9) and 9 x 10(-8). Bleomycin (4 micrograms/ml) sharply increased the frequency of ampicillin-resistant mutants, from 10(-8) (spontaneous) to 4 x 10(-4) (induced), in 17 h. An inducible, error-prone mechanism of DNA synthesis seems to be responsible for this enhancement of the mutagenic effect. this is the first report on the sensitivity to several antibiotics, and capacity of lethality and mutagenesis by bleomycin has been studied in a purple sulfur bacterium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533575     DOI: 10.1007/bf00294193

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  10 in total

Review 1.  General microbiology of recA: environmental and evolutionary significance.

Authors:  R V Miller; T A Kokjohn
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

Review 2.  Genetic research with photosynthetic bacteria.

Authors:  P A Scolnik; B L Marrs
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

3.  Cloning and expression of a structural gene from Chlorobium vibrioforme that complements the hemA mutation in Escherichia coli.

Authors:  Y J Avissar; S I Beale
Journal:  J Bacteriol       Date:  1990-03       Impact factor: 3.490

Review 4.  Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli.

Authors:  G C Walker
Journal:  Microbiol Rev       Date:  1984-03

5.  DNA repair systems in the phototrophic bacterium Rhodobacter capsulatus.

Authors:  J Barbé; I Gibert; M Llagostera; R Guerrero
Journal:  J Gen Microbiol       Date:  1987-04

6.  Restoration of hydrogenase activity in hydrogenase-negative strains of Escherichia coli by cloned DNA fragments from Chromatium vinosum and Proteus vulgaris.

Authors:  A Chaudhuri; A I Krasna
Journal:  J Gen Microbiol       Date:  1990-06

Review 7.  The role of redox-active metals in the mechanism of action of bleomycin.

Authors:  D H Petering; R W Byrnes; W E Antholine
Journal:  Chem Biol Interact       Date:  1990       Impact factor: 5.192

8.  Molecular cloning and characterization of the recA gene from the cyanobacterium Synechococcus sp. strain PCC 7002.

Authors:  R C Murphy; D A Bryant; R D Porter; N T de Marsac
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

9.  DNA polymerase III-dependent repair synthesis in response to bleomycin in toluene-treated Escherichia coli.

Authors:  S L Ross; S Sharma; R E Moses
Journal:  Mol Gen Genet       Date:  1980

10.  Cloning and sequence of the structural (hupSLC) and accessory (hupDHI) genes for hydrogenase biosynthesis in Thiocapsa roseopersicina.

Authors:  A Colbeau; K L Kovacs; J Chabert; P M Vignais
Journal:  Gene       Date:  1994-03-11       Impact factor: 3.688

  10 in total
  2 in total

1.  Isolation and characterization of Saccharomyces cerevisiae mutants with enhanced resistance to the anticancer drug bleomycin.

Authors:  Mustapha Aouida; Omar Tounekti; Anick Leduc; Omrane Belhadj; Lluis Mir; Dindial Ramotar
Journal:  Curr Genet       Date:  2004-03-09       Impact factor: 3.886

Review 2.  Protective mechanisms against the antitumor agent bleomycin: lessons from Saccharomyces cerevisiae.

Authors:  Dindial Ramotar; Huijie Wang
Journal:  Curr Genet       Date:  2003-04-16       Impact factor: 3.886

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.